Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: An open-label, blinded end point, randomized prospective trial (VitD-CHF trial)

American Heart Journal

Volumn 166, Issue 2, 2013, Pages

  Schroten, Nicolas F ^a   Ruifrok, Willem P T ^a   Kleijn, Lennaert ^a   Dokter, Martin M ^a   Silljé, Herman H ^a   Lambers Heerspink, Hiddo J ^a   Bakker, Stephan J L ^a   Kema, Ido P ^a   Van Gilst, Wiek H ^a   Van Veldhuisen, Dirk J ^a   Hillege, Hans L ^a   De Boer, Rudolf A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BUMETANIDE; CALCIFEDIOL; CANDESARTAN; COLECALCIFEROL; ENALAPRIL; FUROSEMIDE; RENIN; VITAMIN D;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

EID: 84880922293     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.05.009     Document Type: Article

References (32)

1. I. Gotsman, A. Shauer, and D.R. Zwas Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome Eur J Heart Fail 14 2012 357 366
2. L. Liu, M. Chen, and S.R. Hankins Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults Am J Cardiol 110 2012 834 839
3. L.M. Meems, P. van der Harst, and W.H. van Gilst Vitamin d biology in heart failure: molecular mechanisms and systematic review Curr Drug Targets 12 2011 29 41
4. L.M. Resnick, F.B. Muller, and J.H. Laragh Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism Ann Intern Med 105 1986 649 654 (Pubitemid 17176965)
5. C.W. Park, Y.S. Oh, and Y.S. Shin Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism Am J Kidney Dis 33 1999 73 81
6. Y. Kimura, M. Kawamura, and M. Owada Effectiveness of 1,25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity Intern Med 38 1999 31 35 (Pubitemid 29093391)
7. Y.C. Li Vitamin D, regulation of the renin-angiotensin system J Cell Biochem 88 2003 327 331
8. C.D. Sigmund Regulation of renin expression and blood pressure by vitamin D(3) J Clin Invest 110 2002 155 156 (Pubitemid 34787350)
9. I. Kuipers, P. van der Harst, and G. Navis Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system Hypertension 51 2008 1442 1448
10. R.M. Fryer, P.A. Rakestraw, and M. Nakane Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice Nephron Physiol 106 2007 p76 p81
11. R. Bouillon, G. Carmeliet, and L. Verlinden Vitamin D and human health: lessons from vitamin D receptor null mice Endocr Rev 29 2008 726 776
12. N.F. Schroten, C.A. Gaillard, and D.J. van Veldhuisen New roles for renin and prorenin in heart failure and cardiorenal crosstalk Heart Fail Rev 17 2012 191 201
13. Authors/Task Force Members, J.J. McMurray, and S. Adamopoulos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
14. H. Schunkert, H.W. Hense, and U. Brockel Differential effects of antihypertensive drugs on neurohormonal activation: insights from a population-based sample J Intern Med 244 1998 109 119 (Pubitemid 28364796)
15. S. Masson, S. Solomon, and L. Angelici Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT) J Card Fail 16 2010 964 970
16. R. Latini, S. Masson, and I. Anand The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT Eur Heart J 25 2004 292 299 (Pubitemid 38295437)
17. M.K. Szymanski, K. Damman, and D.J. van Veldhuisen Prognostic value of renin and prorenin in heart failure patients with decreased kidney function Am Heart J 162 2011 487 493
18. R.M. van de Wal, H.W. Plokker, and D.J. Lok Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition Int J Cardiol 106 2006 367 372 (Pubitemid 41766640)
19. G. Nguyen, and A.H. Danser Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents Exp Physiol 93 2008 557 563 (Pubitemid 351595066)
20. S.R. Holmer, C. Hengstenberg, and B. Mayer Marked suppression of renin levels by beta-receptor blocker in patients treated with standard heart failure therapy: a potential mechanism of benefit from beta-blockade J Intern Med 249 2001 167 172 (Pubitemid 32202507)
21. B. Casetta, I. Jans, and J. Billen Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization Eur J Mass Spectrom (Chichester, Eng) 16 2010 81 89
22. M.F. Holick, N.C. Binkley, and H.A. Bischoff-Ferrari Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline J Clin Endocrinol Metab 96 2011 1911 1930
23. A. Cranney, H.A. Weiler, and S. O'Donnell Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health Am J Clin Nutr 88 2008 513S 519S
24. S.S. Schleithoff, A. Zittermann, and G. Tenderich Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial Am J Clin Nutr 83 2006 754 759 (Pubitemid 44713136)
25. S.A. Shedeed Vitamin d supplementation in infants with chronic congestive heart failure Pediatr Cardiol 33 2012 713 719
26. R. Thadhani, E. Appelbaum, and Y. Pritchett Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial JAMA 307 2012 674 684
27. M.D. Witham, L.J. Crighton, and N.D. Gillespie The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial Circ Heart Fail 3 2010 195 201
28. 3 in patients with heart failure JCHF 1 2013 84 90
29. M.B. Elamin, N.O. Abu Elnour, and K.B. Elamin Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis J Clin Endocrinol Metab 96 2011 1931 1942
30. L. Wang, Y. Song, and J.E. Manson Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies Circ Cardiovasc Qual Outcomes 5 2012 819 829
31. A.D. Wood, K.R. Secombes, and F. Thies Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT J Clin Endocrinol Metab 97 2012 3557 3568
32. J.A. Sugden, J.I. Davies, and M.D. Witham Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels Diabet Med 25 2008 320 325 (Pubitemid 351322698)